Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL7L1P8 is a processed pseudogene found in the human genome, related by sequence homology to the ribosomal protein L7-like 1 gene. Pseudogenes are genetic loci representing defunct copies of functional genes, often derived from retrotransposition events. While the parent gene (such as RPL7 or RPL7L1) plays a role in forming ribosomes for protein synthesis[1][4], pseudogenes themselves do not code for functional proteins and typically have no direct biological or disease roles. Nonetheless, thousands of ribosomal protein pseudogenes, including RPL7L1P8, exist and contribute to genome evolution and dynamics, though their functional impact is minimal or unknown[6]. There is no evidence that RPL7L1 pseudogene 8 is a therapeutic target, marker, or active participant in disease or drug response.
no mechanism, as it is not a target molecule
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7-like 1 pseudogene 8 (RPL7L1P8).